MetaADEDB 2.0 @ LMMD
ARRY-470
(NYNZQNWKBKUAII-KBXCAEBGSA-N)
Structure
SMILES
O[C@H]1CCN(C1)C(=O)Nc1cnn2c1nc(cc2)N1CCC[C@@H]1c1cc(F)ccc1F
Type(s)
Approved; Investigational
Molecular Formula:
C21H22F2N6O2
Molecular Weight:
428.435
Log P:
3.0234
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
86
CAS Number(s):
1223403-58-4
Synonym(s)
1.
ARRY-470
2.
LOXO-101
3.
N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
4.
larotrectinib
External Link(s)
MeSHC000609083
PubChem Compound46188928
BindingDB136597
CHEMBLCHEMBL3889654
DrugBankDB14723
IUPHAR/BPS Guide to PHARMACOLOGY8909
KEGGdr:D11137
ZINC118399834
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 4US FAERS
2FatigueFAERS: 3US FAERS
3Disease ProgressionFAERS: 2US FAERS
4LethargyFAERS: 2US FAERS
5PneumoniaFAERS: 2US FAERS
6PneumothoraxFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Product use in unapproved indicationFAERS: 2US FAERS
8Alanine Aminotransferase IncreasedFAERS: 1US FAERS
9Amyotrophic Lateral SclerosisFAERS: 1US FAERS
10CellulitisFAERS: 1US FAERS
11Drug ineffectiveFAERS: 1US FAERS
12HerniaFAERS: 1US FAERS
13HypersomniaFAERS: 1US FAERS
14HypotensionFAERS: 1US FAERS
15LeukopeniaFAERS: 1US FAERS
16MyalgiaFAERS: 1US FAERS
17NauseaFAERS: 1US FAERS
18Neck PainFAERS: 1US FAERS
19Oropharyngeal painFAERS: 1US FAERS
20PainFAERS: 1US FAERS
21Peripheral swellingFAERS: 1US FAERS
22PruritusFAERS: 1US FAERS
23Restless Legs SyndromeFAERS: 1US FAERS
24Sensitive skinFAERS: 1US FAERS
25SepsisFAERS: 1US FAERS
26TremorFAERS: 1US FAERS
27nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.